DAN STAFFORD advises on a broad range of cross-border private equity and corporate M&A transactions, including acquisitions, disposals, restructurings, management equity arrangements, and joint ventures. Dan also advises on complex cross-border commercial and technology transactions, including strategic collaborations and a broad range of licensing, technology development, and outsourcing transactions, along with related advisory matters.
Dan's practice is focused on representing clients in the technology, healthcare and life sciences industry sectors.
Dan recently spent eight months on secondment at Huma Therapeutics, a digital health company whose technology is used across the UK, Europe, Asia, and the Middle East to power “hospital at home” virtual wards and decentralized clinical trials. Whilst at Huma Therapeutics, Dan advised on various corporate M&A and commercial matters, including a number of strategic collaboration and software development and licensing transactions.
Dan is a member of the team that was honored as “Private Equity Team of the Year” at the 2021 Legal Business Awards.